SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-21-028316
Filing Date
2021-11-15
Accepted
2021-11-15 07:00:27
Documents
34
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form6-k.htm   iXBRL 6-K 24498
2 ex99-1.htm EX-99.1 34937
3 ex99-2.htm   iXBRL EX-99.2 388027
4 ex99-3.htm EX-99.3 111596
  Complete submission text file 0001493152-21-028316.txt   2058940

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE vblt-20210930.xsd EX-101.SCH 15895
6 XBRL CALCULATION FILE vblt-20210930_cal.xml EX-101.CAL 37587
7 XBRL DEFINITION FILE vblt-20210930_def.xml EX-101.DEF 54590
8 XBRL LABEL FILE vblt-20210930_lab.xml EX-101.LAB 180551
9 XBRL PRESENTATION FILE vblt-20210930_pre.xml EX-101.PRE 127617
10 EXTRACTED XBRL INSTANCE DOCUMENT form6-k_htm.xml XML 117939
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36581 | Film No.: 211406231
SIC: 2834 Pharmaceutical Preparations